HomeIUI1 • FRA
Intuitive Surgical, Inc.
€551.70
Jan 31, 10:59:41 PM GMT+1 · EUR · FRA · Disclaimer
StockDE listed securityUS headquartered
Previous close
€562.10
Day range
€551.70 - €565.00
Year range
€325.05 - €566.30
Market cap
203.69B USD
Avg Volume
87.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
CDP Climate Change Score
C
In the news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
2.41B25.16%
Operating expense
907.30M9.68%
Net income
685.70M13.11%
Net profit margin
28.41-9.64%
Earnings per share
2.2138.12%
EBITDA
851.10M53.68%
Effective tax rate
15.04%—
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
8.83B69.10%
Total assets
18.74B21.38%
Total liabilities
2.21B8.29%
Total equity
16.53B—
Shares outstanding
356.40M—
Price to book
12.12—
Return on assets
10.07%—
Return on capital
11.41%—
Net change in cash
(USD)Dec 2024Y/Y change
Net income
685.70M13.11%
Cash from operations
——
Cash from investing
——
Cash from financing
——
Net change in cash
——
Free cash flow
——
About
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world. Intuitive Surgical made its debut on the Fortune 500 list in 2024, ranking #497. Wikipedia
Founded
1995
Employees
13,676
Search
Clear search
Close search
Google apps
Main menu